A calcineurin antagonist-free induction strategy for immunosuppression in cadaveric kidney transplant recipients at risk for delayed graft function.
about
Sirolimus: a comprehensive review.Clinical application of sirolimus in renal transplantation: an update.Risk factors for impaired wound healing in sirolimus-treated renal transplant recipients.Toxicity spectrum of inhibitors of mammalian target of rapamycin in organ transplantation: etiology, pathogenesis and treatment.Adverse events associated with mTOR inhibitors.mTOR inhibitors and renal allograft: Yin and Yang.Sulodexide alone or in combination with low doses of everolimus inhibits the hypoxia-mediated epithelial to mesenchymal transition in human renal proximal tubular cells.Anti-interleukin-2 receptor antibodies-basiliximab and daclizumab-for the prevention of acute rejection in renal transplantation.The role of basiliximab in the evolving renal transplantation immunosuppression protocol.Calcineurin inhibitor-free immunosuppression in dual kidney transplantation from elderly donors.Calcineurin inhibitor-free immunosuppression based on antithymocyte globulin and mycophenolate mofetil in cadaveric kidney transplantation: results after 5 years.Rapamycin in patients with chronic renal allograft dysfunction.Impact of initial exposure to calcineurin inhibitors on kidney graft function of patients at high risk to develop delayed graft function.Renal calcium handling after rapamycin conversion in chronic allograft dysfunction.
P2860
Q34515537-036811E2-F334-4A28-A325-70323B99849BQ36054093-A0238734-6B40-420B-8222-E557727D8416Q36889289-634030EF-B606-4C81-BF07-D2E1F08034CEQ37873950-B2C4CADE-76A3-41AD-A850-4EAF44C541FAQ38068519-70DFEA65-8EB5-449D-9961-4AF4C5533B7DQ38209973-EB8D3F3C-B4BB-4492-995E-730736F98A13Q38866153-FD2D2C0C-D7BE-4C42-B9C4-F1D1818D49FEQ43071206-EC3B74F9-8EFC-4BEC-9623-FD1C948C2A6DQ43078141-841B53B1-A190-4138-972B-9E94F45A8312Q43823533-F5E147DA-DAC5-4E90-A9D9-6212C76A4441Q44524563-69872169-2C25-4AF9-8E4A-09516EF63B99Q45289882-E09FA7ED-9FAF-4AC0-B04C-43545A066E9DQ46885126-FA5DC12E-CF02-4F64-B762-0A9518CED423Q46915002-E72A3189-3FAE-492D-A19C-5F0A4B958E4C
P2860
A calcineurin antagonist-free induction strategy for immunosuppression in cadaveric kidney transplant recipients at risk for delayed graft function.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
A calcineurin antagonist-free ...... sk for delayed graft function.
@en
A calcineurin antagonist-free ...... sk for delayed graft function.
@nl
type
label
A calcineurin antagonist-free ...... sk for delayed graft function.
@en
A calcineurin antagonist-free ...... sk for delayed graft function.
@nl
prefLabel
A calcineurin antagonist-free ...... sk for delayed graft function.
@en
A calcineurin antagonist-free ...... sk for delayed graft function.
@nl
P1433
P1476
A calcineurin antagonist-free ...... sk for delayed graft function.
@en
P2093
P304
P356
10.1097/00007890-200105150-00025
P577
2001-05-01T00:00:00Z